ArticleJournal of medicinal chemistry2026
C-BODIPY Dyads Based on Fused-Ring Organoboron Scaffolds for Efficient Photodynamic Therapy Targeting
Article in Journal of medicinal chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A series of heavy-atom-free C-BODIPY photosensitizers based on five different types of fused-ring organoboron scaffolds was designed for the application in antifungal photodynamic therapy. The dyes were functionalized with a positively charged quaternary ammonium group or zwitterionic 3-(ethyldimethylammonio)propane-1-sulfonate unit. Spectroscopic, electrochemical, and photocatalytic studies supported by DFT calculations revealed the crucial role of the organoboron structure on triplet-state generation. Most of the BODIPY complexes display high ROS generation with a type I/type II ROS ratio depending on the electronic structure of the boracycle unit. Antifungal studies demonstrated remarkable efficacy against the opportunistic yeast
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.